Facilitating oral COVID-19 therapy utilization through a pharmacy consult service

BACKGROUND: Two oral therapies, nirmatrelvir/ritonavir (Paxlovid) and molnupiravir (Lagevrio), are now available for the treatment of coronavirus disease 2019 (COVID-19). Treatment guidelines recommend using these agents for nonhospitalized adults with mild to moderate COVID-19 who are at high risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Portman, David Brennan, Scolese, Ce Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Advances in Pharmacy Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116126/
https://www.ncbi.nlm.nih.gov/pubmed/37084811
http://dx.doi.org/10.1016/j.japh.2023.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116126/
https://www.ncbi.nlm.nih.gov/pubmed/37084811
http://dx.doi.org/10.1016/j.japh.2023.04.010

Ejemplares similares